An epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle

Journal of Virology

Volumn 88, Issue 11, 2014, Pages 6047-6060

  Li, Gang ^a   Rak, Michael ^b,c   Nguyen, Christopher C ^a   Umashankar, Mahadevaiah ^c   Goodrum, Felicia D ^b,c   Kamil, Jeremy P ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN KINASE; PROTEIN KINASE UL97; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INHIBITION; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENOME; HUMAN CYTOMEGALOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHENOTYPE; PRIORITY JOURNAL; UL133 GENE; UL138 GENE; VIRAL LYTIC CYCLE; VIRAL PHENOMENA AND FUNCTIONS; VIRUS GENE; VIRUS LATENCY; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

BENZIMIDAZOLES; BLOTTING, WESTERN; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CYTOMEGALOVIRUS; DNA PRIMERS; EPISTASIS, GENETIC; HUMANS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); REAL-TIME POLYMERASE CHAIN REACTION; RIBONUCLEOSIDES; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 84899860286     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00447-14     Document Type: Article

References (61)

1. Mocarski ES, Shenk T, Griffiths PD, Pass RF. 2013. Cytomegaloviruses, p 1960-2014. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed (electronic), vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Prichard MN. 2009. Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir. Rev. Med. Virol. 19:215-229. http://dx. doi. org/10. 1002/rmv. 615.
3. Biron KK. 2006. Antiviral drugs for cytomegalovirus diseases. Antiviral Res. 71:154-163. http://dx. doi. org/10. 1016/j. antiviral. 2006. 05. 002.
4. Hume AJ, Finkel JS, Kamil JP, Coen DM, Culbertson MR, Kalejta RF. 2008. Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320:797-799. http://dx. doi. org/10. 1126/science. 1152095.
5. Prichard MN, Sztul E, Daily SL, Perry AL, Frederick SL, Gill RB, Hartline CB, Streblow DN, Varnum SM, Smith RD, Kern ER. 2008. Human cytomegalo virus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes. J. Virol. 82:5054-5067. http://dx. doi. org/10. 1128/JVI. 02174-07.
6. Marschall M, Marzi A, Aus Dem Siepen P, Jochmann R, Kalmer M, Auerochs S, Lischka P, Leis M, Stamminger T. 2005. Cellular p32 recruits cytomegalovirus kinasepUL97to redistribute the nuclear lamina. J. Biol. Chem. 280:33357-33367. http://dx. doi. org/10. 1074/jbc. M502672200.
7. Hamirally S, Kamil JP, Ndassa-Colday YM, Lin AJ, Jahng WJ, Baek MC, Noton S, Silva LA, Simpson-Holley M, Knipe DM, Golan DE, Marto JA, Coen DM. 2009. Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress. PLoS Pathog. 5:e1000275. http://dx. doi. org/10. 1371/journal. ppat. 1000275.
8. Reim NI, Kamil JP, Wang D, Lin A, Sharma M, Ericsson M, Pesola JM, Golan DE, Coen DM. 2013. Inactivation of retinoblastoma protein does not overcome the requirement for human cytomegalovirus UL97 in lamina disruption and nuclear egress. J. Virol. 87:5019-5027. http://dx. doi. org/10. 1128/JVI. 00007-13.
9. Dyson N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262. http://dx. doi. org/10. 1101/gad. 12. 15. 2245.
10. Kamil JP, Hume AJ, Jurak I, Munger K, Kalejta RF, Coen DM. 2009. Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase. Proc. Natl. Acad. Sci. USA. 106:16823-16828. http://dx. doi. org/10. 1073/pnas. 0901521106.
11. Krosky PM, Baek MC, Coen DM. 2003. The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol. 77:905-914. http://dx. doi. org/10. 1128/JVI. 77. 2. 905-914. 2003.
12. Sharma M, Kamil JP, Coughlin M, Reim NI, Coen DM. 2014. Human cytomegalo virus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells. J. Virol. 88:249-262. http://dx. doi. org/10. 1128/JVI. 02358-13.
13. Tran K, Kamil JP, Coen DM, Spector DH. 2010. Inactivation and disassembly of the anaphase-promoting complex during human cytomegalovirus infection is associated with degradation of the APC5 and APC4 subunits and does not require UL97-mediated phosphorylation of Cdh1. J. Virol. 84:10832-10843. http://dx. doi. org/10. 1128/JVI. 01260-10.
14. Fehr AR, Gualberto NC, Savaryn JP, Terhune SS, Yu D. 2012. Proteasome-dependent disruption of the E3 ubiquitin ligase anaphasepromoting complex by HCMV protein pUL21a. PLoS Pathog. 8:e1002789. http://dx. doi. org/10. 1371/journal. ppat. 1002789.
15. Hobom U, Brune W, Messerle M, Hahn G, Koszinowski UH. 2000. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J. Virol. 74:7720-7729. http://dx. doi. org/10. 1128/JVI. 74. 17. 7720-7729. 2000.
16. Sinzger C, Hahn G, Digel M, Katona R, Sampaio KL, Messerle M, Hengel H, Koszinowski U, Brune W, Adler B. 2008. Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J. Gen. Virol. 89:359-368. http://dx. doi. org/10. 1099/vir. 0. 83286-0.
17. Wang D, Li G, Schauflinger M, Nguyen CC, Hall ED, Yurochko AD, von Einem J, Kamil JP. 2013. The ULb' region of the human cytomegalovirus genomeconfersan increased requirement for the viral protein kinaseUL97. J. Virol. 87:6359-6376. http://dx. doi. org/10. 1128/JVI. 03477-12.
18. Umashankar M, Petrucelli A, Cicchini L, Caposio P, Kreklywich CN, Rak M, Bughio F, Goldman DC, Hamlin KL, Nelson JA, Fleming WH, Streblow DN, Goodrum F. 2011. A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection. PLoS Pathog. 7:e1002444. http://dx. doi. org/10. 1371/journal. ppat. 1002444.
19. Umashankar M, Rak M, Bughio F, Zagallo P, Caviness K, Goodrum FD. 2014. Antagonistic determinants controlling replicative and latent states of human cytomegalovirus infection. J. Virol. 88:5987-6002. http://dx. doi. org/10. 1128/JVI. 03506-13.
20. Tischer BK, Smith GA, Osterrieder N. 2010. En passant mutagenesis: a two step markerless Red recombination system. Methods Mol. Biol. 634: 421-430. http://dx. doi. org/10. 1007/978-1-60761-652-8_30.
21. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step Red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 40:191-197. http://dx. doi. org/10. 2144/000112096.
22. McSharry JJ, McDonough A, Olson B, Talarico C, Davis M, Biron KK. 2001. Inhibition of ganciclovir-susceptible and-resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94. Clin. Diagn. Lab. Immunol. 8:1279-1281. http://dx. doi. org/10. 1128/CDLI. 8. 6. 1279-1281. 2001.
23. Biron KK, Harvey RJ, Chamberlain SC, Good SS, Smith AA, III, Davis MG, Talarico CL, Miller WH, Ferris R, Dornsife RE, Stanat SC, Drach JC, Townsend LB, Koszalka GW. 2002. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob. Agents Chemother. 46: 2365-2372. http://dx. doi. org/10. 1128/AAC. 46. 8. 2365-2372. 2002.
24. Petrucelli A, Rak M, Grainger L, Goodrum F. 2009. Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus. J. Virol. 83:5615-5629. http://dx. doi. org/10. 1128/JVI. 01989-08.
25. Nogalski MT, Chan G, Stevenson EV, Gray S, Yurochko AD. 2011. Human cytomegalovirus-regulated paxillin in monocytes links cellular pathogenic motility to the process of viral entry. J. Virol. 85:1360-1369. http://dx. doi. org/10. 1128/JVI. 02090-10.
26. Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, Rotter V. 2004. Activated p53 suppresses the histone methyltransferase EZH2 gene. Oncogene 23:5759-5769. http://dx. doi. org/10. 1038/sj. onc. 1207706.
27. Fehr AR, Yu D. 2011. Human cytomegalovirus early protein pUL21a promotes efficient viral DNA synthesis and the late accumulation of immediate-early transcripts. J. Virol. 85:663-674. http://dx. doi. org/10. 1128/JVI. 01599-10.
28. Stamminger T, Puchtler E, Fleckenstein B. 1991. Discordant expression of the immediate-early 1 and 2 gene regions of human cytomegalovirus at early times after infection involves posttranscriptional processing events. J. Virol. 65:2273-2282.
29. Stenberg RM, Depto AS, Fortney J, Nelson JA. 1989. Regulated expression of early and late RNAs and proteins from the human cytomegalovirus immediate-early gene region. J. Virol. 63:2699-2708.
30. Stenberg RM, Witte PR, Stinski MF. 1985. Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. J. Virol. 56:665-675.
31. Tomasec P, Wang EC, Davison AJ, Vojtesek B, Armstrong M, Griffin C, McSharry BP, Morris RJ, Llewellyn-Lacey S, Rickards C, Nomoto A, Sinzger C, Wilkinson GW. 2005. Downregulation of natural killer cellactivating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol. 6:181-188. http://dx. doi. org/10. 1038/ni1156.
32. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
33. Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, Hahn G, Nelson JA, Myers RM, Shenk TE. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. USA. 100:14976-14981. http://dx. doi. org/10. 1073/pnas. 2136652100.
34. Cunningham C, Gatherer D, Hilfrich B, Baluchova K, Dargan DJ, Thomson M, Griffiths PD, Wilkinson GW, Schulz TF, Davison AJ. 2010. Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J. Gen. Virol. 91:605-615. http://dx. doi. org/10. 1099/vir. 0. 015891-0.
35. Puchtler E, Stamminger T. 1991. An inducible promoter mediates abundant expression from the immediate-early 2 gene region of human cytomegalovirus at late times after infection. J. Virol. 65:6301-6306.
36. Bughio F, Elliott DA, Goodrum F. 2013. An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturation. J. Virol. 87:3062-3075. http://dx. doi. org/10. 1128/JVI. 02510-12.
37. Michel D, Pavic I, Zimmermann A, Haupt E, Wunderlich K, Heuschmid M, Mertens T. 1996. The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J. Virol. 70:6340-6346.
38. Teng MW, Bolovan-Fritts C, Dar RD, Womack A, Simpson ML, Shenk T, Weinberger LS. 2012. An endogenous accelerator for viral gene expression confers a fitness advantage. Cell 151:1569-1580. http://dx. doi. org/10. 1016/j. cell. 2012. 11. 051.
39. Burkhart DL, Sage J. 2008. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat. Rev. Cancer 8:671-682. http://dx. doi. org/10. 1038/nrc2399.
40. Gribaudo G, Riera L, Lembo D, De Andrea M, Gariglio M, Rudge TL, Johnson LF, Landolfo S. 2000. Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication. J. Virol. 74:4979-4987. http://dx. doi. org/10. 1128/JVI. 74. 11. 4979-4987. 2000.
41. Lembo D, Gribaudo G, Riera L, Mondo A, Cavallo R, Angeretti A, Landolfo S. 2000. The thymidylate synthase inhibitor ZD1694 potently inhibits murine and human cytomegalovirus replication in quiescent fibroblasts. Antiviral Res. 47:111-120. http://dx. doi. org/10. 1016/S0166-3542(00)00096-6.
42. Hagemeier C, Caswell R, Hayhurst G, Sinclair J, Kouzarides T. 1994. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J. 13:2897-2903.
43. Sommer MH, Scully AL, Spector DH. 1994. Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J. Virol. 68:6223-6231.
44. Song YJ, Stinski MF. 2002. Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: a DNA microarray analysis. Proc. Natl. Acad. Sci. USA. 99:2836-2841. http://dx. doi. org/10. 1073/pnas. 052010099.
45. Choi KS, Kim SJ, Kim S. 1995. The retinoblastoma gene product negatively regulates transcriptional activation mediated by the human cytomegalovirus IE2 protein. Virology 208:450-456. http://dx. doi. org/10. 1006/viro. 1995. 1175.
46. Brehm A, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601. http://dx. doi. org/10. 1038/35404.
47. Magnaghi-Jaulin L, Groisman R, Naguibneva I, Robin P, Lorain S, Le Villain JP, Troalen F, Trouche D, Harel-Bellan A. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-605. http://dx. doi. org/10. 1038/35410.
48. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE, Kouzarides T. 2001. Rb targets histone H3 methylation and HP1 to promoters. Nature 412:561-565. http://dx. doi. org/10. 1038/35087620.
49. Vandel L, Nicolas E, Vaute O, Ferreira R, Ait-Si-Ali S, Trouche D. 2001. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol. Cell. Biol. 21:6484-6494. http://dx. doi. org/10. 1128/MCB. 21. 19. 6484-6494. 2001.
50. Reeves M, Murphy J, Greaves R, Fairley J, Brehm A, Sinclair J. 2006. Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86. J. Virol. 80:9998-10009. http://dx. doi. org/10. 1128/JVI. 01297-06.
51. Bigley TM, Reitsma JM, Mirza SP, Terhune SS. 2013. Human cytomegalovirus pUL97 regulates the viral major immediate early promoter by phosphorylation-mediated disruption of histone deacetylase 1 binding. J. Virol. 87:7393-7408. http://dx. doi. org/10. 1128/JVI. 02825-12.
52. Cuevas-Bennett C, Shenk T. 2008. Dynamic histone H3 acetylation and methylation at human cytomegalovirus promoters during replication in fibroblasts. J. Virol. 82:9525-9536. http://dx. doi. org/10. 1128/JVI. 00946-08.
53. Toth Z, Brulois K, Lee HR, Izumiya Y, Tepper C, Kung HJ, Jung JU. 2013. Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection. PLoS Pathog. 9:e1003813. http://dx. doi. org/10. 1371/journal. ppat. 1003813.
54. Abraham CG, Kulesza CA. 2013. Polycomb repressive complex 2 silences human cytomegalovirus transcription in quiescent infection models. J. Virol. 87:13193-13205. http://dx. doi. org/10. 1128/JVI. 02420-13.
55. Knipe DM, Lieberman PM, Jung JU, McBride AA, Morris KV, Ott M, Margolis D, Nieto A, Nevels M, Parks RJ, Kristie TM. 2013. Snapshots: chromatin control of viral infection. Virology 435:141-156. http://dx. doi. org/10. 1016/j. virol. 2012. 09. 023.
56. Nitzsche A, Paulus C, Nevels M. 2008. Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells. J. Virol. 82:11167-11180. http://dx. doi. org/10. 1128/JVI. 01218-08.
57. Nitzsche A, Steinhausser C, Mucke K, Paulus C, Nevels M. 2012. Histone H3 lysine 4 methylation marks postreplicative human cytomegalovirus chromatin. J. Virol. 86:9817-9827. http://dx. doi. org/10. 1128/JVI. 00581-12.
58. Woodhall DL, Groves IJ, Reeves MB, Wilkinson G, Sinclair JH. 2006. Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J. Biol. Chem. 281:37652-37660. http://dx. doi. org/10. 1074/jbc. M604273200.
59. Zalckvar E, Paulus C, Tillo D, Asbach-Nitzsche A, Lubling Y, Winterling C, Strieder N, Mucke K, Goodrum F, Segal E, Nevels M. 2013. Nucleosome maps of the human cytomegalovirus genome reveal a temporal switch in chromatin organization linked to a major IE protein. Proc. Natl. Acad. Sci. USA. 110:13126-13131. http://dx. doi. org/10. 1073/pnas. 1305548110.
60. Sinclair J. 2008. Human cytomegalovirus: latency and reactivation in the myeloid lineage. J. Clin. Virol. 41:180-185. http://dx. doi. org/10. 1016/j. jcv. 2007. 11. 014.
61. Taylor-Wiedeman J, Sissons P, Sinclair J. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597-1604.